Drug intelligence / Profile preview

Xiaoshuan enteric-coated capsules

Development stage
Phase 4
Lead developer
Sanmenxia Sinoway Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xiaoshuan enteric-coated capsule (XSECC) is a compound Traditional Chinese Medicine (TCM) preparation derived from the classical formula Buyang Huanwu Decoction (BYHWD). It is approved by the China National Medical Products Administration (NMPA) for the management of stroke and cerebral infarction, specifically to promote brain remodeling and plasticity. The formulation is manufactured by Sanmenxia Sinoway Pharmaceutical. It is currently being investigated in Phase 4 clinical trials for the treatment of fatigue syndrome following cardiovascular and cerebrovascular events, such as myocardial infarction and coronary heart disease treated with percutaneous coronary intervention (PCI). Its mechanism involves neurovascular modulation, including the regulation of Vascular Endothelial Growth Factor (VEGF) and Brain-Derived Neurotrophic Factor (BDNF).

Brand names
Xiaoshuan
Other names
Xiaoshuan enteric-coated capsuleXSECCXiaoshuan Changrong Jiaonang
02

Targets

Beyond the preview

Go deeper on Xiaoshuan enteric-coated capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoshuan enteric-coated capsules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call